Dow Up 0.12% Nasdaq Up 1.35%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
168.20 Up 3.45(2.09%) Oct 20, 4:00PM EDT
|After Hours : 168.20 0.00 (0.00%) Oct 20, 5:01PM EDT
Prev Close:164.75
Open:164.49
Bid:165.89 x 100
Ask:184.94 x 100
1y Target Est:198.57
Beta:1.07
Next Earnings Date:23-Oct-14ALXN Earnings announcement
Day's Range:164.27 - 169.58
52wk Range:100.89 - 185.43
Volume:1,179,649
Avg Vol (3m):1,178,570
Market Cap:33.27B
P/E (ttm):84.31
EPS (ttm):2.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 2.09%33.27B
AMGNUp 2.86%104.45B
BAXUp 1.04%36.80B

Key Statistics

Forward P/E (1 yr):29.35
P/S (ttm):16.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback